Financials data is unavailable for this security.
View more
Year on year Eurofins Scientific SE 's net income fell -49.16% from 610.10m to 310.20m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 77.46% to 79.07%.
Gross margin | 22.02% |
---|---|
Net profit margin | 9.32% |
Operating margin | 14.02% |
Return on assets | 5.94% |
---|---|
Return on equity | 11.25% |
Return on investment | 7.22% |
More ▼
Cash flow in EURView more
In 2023, Eurofins Scientific SE increased its cash reserves by 152.67%, or 737.70m. The company earned 1.02bn from its operations for a Cash Flow Margin of 15.63%. In addition the company generated 413.60m cash from financing while 681.10m was spent on investing.
Cash flow per share | 6.17 |
---|---|
Price/Cash flow per share | 7.26 |
Book value per share | 27.40 |
---|---|
Tangible book value per share | -1.61 |
More ▼
Balance sheet in EURView more
Current ratio | 1.42 |
---|---|
Quick ratio | 1.34 |
Total debt/total equity | 0.676 |
---|---|
Total debt/total capital | 0.4009 |
More ▼
Growth rates in EUR
SmartText is unavailable
Div yield(5 year avg) | 0.90% |
---|---|
Div growth rate (5 year) | 11.66% |
Payout ratio (TTM) | 33.45% |
EPS growth(5 years) | 9.19 |
---|---|
EPS (TTM) vs TTM 1 year ago | 13.11 |
More ▼